Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935221

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1935221

Neurological Disorder Diagnostics Market, By Technology, By Disease Indication, By End User, By Geography

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Neurological Disorder Diagnostics Market is estimated to be valued at USD 13.76 Bn in 2026 and is expected to reach USD 15.87 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 13.76 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.10% 2033 Value Projection: USD 15.87 Bn

Neurological disorder diagnostic tools are used for the diagnosis of various neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease and others. Neurological disorders can be diagnosed with the use of imaging and in vitro diagnostic techniques. Imaging techniques such as computed tomography (CT) and magnetic resonance imaging (MRI) are used to create detailed images of organs, bones, soft tissue, blood vessels, and other parts of body. Whereas, in-vitro diagnostic techniques include biopsy, biomarker, blood test, urine test, and genetic testing.

Market Dynamics

Technological innovations and developments in neurological disorder diagnosing devices are expected to drive the market growth. For instance, in 2017, Neusoft Medical Systems developed an innovative CT scanner NeuViz Prime CT Scanner and received the U.S. Food and Drug Administration approval for the system. Moreover in 2016, Koninklijke Philips N.V. launched IQon Spectral CT in Canada. IQon Spectral CT is a spectral detector CT, designed specifically for spectral imaging.

Key features of the study

  • This report provides in-depth analysis of the global neurological disorder diagnostics market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global neurological disorder diagnostics market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Siemens Healthineers, Koninklijke Philips N.V., General Electric Company, Esaote SpA, NeuroLogica Corporation, Masimo Corporation, York Instruments Ltd., Neusoft Medical Systems, and Canon Medical Systems Corporation
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology upgradation, market expansion, and marketing tactics
  • The global neurological disorder diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurological disorder diagnostics market

Market Segmentation

  • By Technology
    • Imaging
    • In Vitro Diagnostics
  • By Disease Indication
    • Genetic Neurological Disorders
    • Immunological Neurological Disorders
    • Paraneoplastic Syndrome
    • Paraproteinemic Neuropathies
    • Others
  • By End User
    • Hospitals & Clinics
    • Diagnostic Centers
    • Ambulatory Care Centers
  • By Regional Insights
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Siemens Healthineers
    • Koninklijke Philips N.V.
    • General Electric Company
    • Esaote SpA
    • NeuroLogica Corporation
    • Masimo Corporation
    • York Instruments Ltd.
    • Neusoft Medical Systems
    • Canon Medical Systems Corporation
Product Code: CMI1867

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Disease Indication
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trend

4. Global Neurological Disorder Diagnostics Market, By Technology, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Imaging
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • In Vitro Diagnostics
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

5. Global Neurological Disorder Diagnostics Market, By Disease Indication, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Genetic Neurological Disorders
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Immunological Neurological Disorders
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Paraneoplastic Syndrome
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Paraproteinemic Neuropathies
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

6. Global Neurological Disorder Diagnostics Market, By End User, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals & Clinics
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Diagnostics Centers
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Ambulatory Care Centers
    • Market Share Analysis, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends

7. Global Neurological Disorder Diagnostics Market, By Region, 2026-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • North America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
    • Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
    • Market Size and Forecast, By Technology, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By End User, 2026- 2033, (USD Bn)
    • Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • Siemens Healthineers
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Koninklijke Philips N.V.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • General Electric Company
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Esaote SpA
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • NeuroLogica Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Masimo Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • York Instruments Ltd.
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Neusoft Medical Systems
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates
    • Canon Medical Systems Corporation
      • Company Overview
      • Product Type Portfolio
      • Recent Developments/Updates

9. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Section

  • References
  • Research Methodology
  • About Us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!